Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

David F. Hale - aVenture Research

David F. Hale

AddedMar 31, 2024

UpdatedOct 11, 2026

David F. Hale

David F. Hale

Founder & CEO, Mdrejuvena

David F. Hale's Career

Biocept

David F. Hale's Co-Investors

David PyottCo-invested · Zerigo Health Seed

Gerry ProehlCo-invested · Zerigo Health Seed

Yann PhungCo-invested · Zerigo Health Seed

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

David F. Hale's Investments

1 investments since 2015

1 operating

Investments view

Group by

2015

1

Zerigo Health
Seed · December 2015$1.4M
Seed · December 2015

Public

$48.2M

San Diego, CA, US

Board Member· Board

Oncternal Therapeutics

Public$132MSan Diego, CA, US

Board Member· Board

Mdrejuvena

$3MSan Diego, CA, US

Founder & CEO· C-Suite · Management

Founder

Viagene

Seed$1MLutz, FL, US

Founder

BioClarity

Series B$13MSan Diego, CA, US

Founder

Recros Medica

Series A$14.7MSan Diego, CA, US

Board Member· Board

Co-Founder

Neurana Pharmaceuticals

Series A$60MSan Diego, CA, US

Board Member· Board

Neurelis

Public$206.1MSan Diego, CA, US

Board Member· Board

Co-Founder

People Similar to David F. Hale

soonkap hahnFounder · Biocept

Harry StylliFounder · Biora Therapeutics

Neal WalkerBoard Member · Aclaris Therapeutics

Doug LevinsonCo-Founder & CEO · Fount Bio

Halley GilbertBoard Member · Arcutis Biotherapeutics

Leadership at Biocept

Ivor RoystonBoard Member

M. Faye WilsonBoard Member

Antonino MoralesCEO

Sam RiccitelliBoard Member

Marsha A. ChandlerBoard Member

Bruce E. GerhardtBoard Member

Similar to Biocept

OnCirc DiagnosticsBeverly Hills, CA, USCancer Diagnosticsest. 2009OnCirc DiagnosticsBeverly Hills, CA, US · est. 2009

Innovative cancer diagnostics biotech in Beverly Hills.

Pre-Seed · $500k30

Leadership at Oncternal Therapeutics

Michael G. CarterBoard Member

William R. LaRueBoard Member

Daniel KisnerBoard Member

Cam GallagherBoard Member

Charles TheuerBoard Member

Scott GlennBoard Member

Similar to Oncternal Therapeutics

CytomX TherapeuticsSouth San Francisco, CA, USCancer Treatmentsest. 2010CytomX TherapeuticsSouth San Francisco, CA, US · est. 2010

CytomX Therapeutics: A US-based oncology-focused biopharmaceutical firm specializing in probody cancer treatments.

Public · $345.4M174

Similar to Mdrejuvena

MD CompleteTerrace Park, OH, USCosmetics, Skincareest. 2012MD CompleteTerrace Park, OH, US · est. 2012

MD Complete Skincare: Premium, cruelty-free skincare solutions including acne and anti-aging treatments.

Series A · $7.4M30

Rejuvel Bio-SciencesMiami, FL, USProducts, Skincareest. 2009Rejuvel Bio-SciencesMiami, FL, US · est. 2009

Rejuvel Bio-Sciences Inc.: A tech-based skincare product developer and distributor.

BeutofullnessRexburg, ID, USBeauty Productsest. 2017BeutofullnessRexburg, ID, US · est. 2017

Idaho-based manufacturer offering personalized beauty solutions to enhance your unique inner and outer beauty.

All BeautyNew York City, NY, USBeverages, Skincareest. 2013All BeautyNew York City, NY, US · est. 2013

All Beauty® Water: Skincare drink designed to hydrate, nourish skin, and promote beauty from within.

Pre-Seed · $50k18

Similar to Viagene

Genetix FusionSt. Louis, MO, USTransfection Kitsest. 2012Genetix FusionSt. Louis, MO, US · est. 2012

Genetix Fusion LLC: A leading biotech supplier of non-toxic transfection kits for research.

Pre-Seed · $50k5

Zymo ResearchIrvine, CA, USReagent Kitsest. 1994Zymo ResearchIrvine, CA, US · est. 1994

Leading provider of reagent kits in life sciences

TopogenPort Orange, FL, USDiagnostics, Researchest. 1991TopogenPort Orange, FL, US · est. 1991

TopoGEN, a research and diagnostics firm, offers products and services for topoisomerase researchers.

Innovative GeneticsMiami, FL, USExtraction Systemsest. 2017Innovative GeneticsMiami, FL, US · est. 2017

Innovative Genetics: A pioneering biotech firm and dependable provider of extraction systems.

Angel · $300k75

Similar to BioClarity

True BotanicalsMill Valley, CA, USSkincare Productsest. 2014True BotanicalsMill Valley, CA, US · est. 2014

True Botanicals offers luxury, health-conscious skincare products, packed with bio-active ingredients for all skin types.

Series B · $18.6M49

Herbivore BotanicalsSeattle, WA, USSkincareest. 2011Herbivore BotanicalsSeattle, WA, US · est. 2011

Herbivore Botanicals: A non-toxic clean beauty brand, crafting organic, high-quality skincare from scratch, for optimum skin health.

Series A · $15M67

BloomeffectsNew York City, NY, USBeauty Products, Skincareest. 2019BloomeffectsNew York City, NY, US · est. 2019

Bloomeffects: Providing clean, safe, and eco-friendly beauty products for mindful skincare.

Veracity SelfcareNew York City, NY, USSkincare, Supplementsest. 2020Veracity SelfcareNew York City, NY, US · est. 2020

Veracity: Personalized skincare solutions based on your unique hormonal and biofactor data.

Seed · $5.9M15

Leadership at Recros Medica

Edward KnowltonCo-Founder

Tom AlbrightBoard Member

Cathy McCarthyCo-Founder

Similar to Recros Medica

MedicreationsLas Vegas, NV, USMedical Devicesest. 2016MedicreationsLas Vegas, NV, US · est. 2016

Medicreations: A Las Vegas-based medical device manufacturer, serving practitioners since 2016.

Alure MedicalSanta Rosa, CA, USMedical Devicesest. 2007Alure MedicalSanta Rosa, CA, US · est. 2007

Alure Medical: Innovating aesthetic solutions with soft tissue lift devices from Santa Rosa, CA.

Series A · $4.5M5

SientraSanta Barbara, CA, USMedical Devicesest. 2003SientraSanta Barbara, CA, US · est. 2003

Sientra, Inc.: US-based manufacturer and marketer of plastic surgery and aesthetic medicine devices.

Public · $334.7M304

Akros MedicalDurham, NC, USSurgical Solutionsest. 2014Akros MedicalDurham, NC, US · est. 2014

Akros Medical: Innovating orthopedic surgery solutions since 2014, based in Durham, NC.

Seed · $1.1M30

Leadership at Neurana Pharmaceuticals

Alex ZissonBoard Member

David S. KabakoffBoard Member

Judy CaronFounder

J Craig ThompsonCEO

Similar to Neurana Pharmaceuticals

NeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30

Leadership at Neurelis

Craig ChamblissCo-Founder

Cam GarnerBoard Member

David SmithBoard Member

Steve CarttBoard Member

Similar to Neurelis

NeurolixisSan Diego, CA, USPharmaceuticalsest. 2011NeurolixisSan Diego, CA, US · est. 2011

San Diego-based Neurolixis, a biopharmaceutical firm innovating treatments for central nervous system diseases.

OncocyteIrvine, CA, USCancer Diagnosticsest. 2009

OncocyteIrvine, CA, US · est. 2009

Oncocyte Corporation: A US-based molecular diagnostics firm, optimizing cancer care through accelerated diagnosis and treatment.

Public · $57.2M75

Castle BiosciencesFriendswood, TX, USCancer Testsest. 2008Castle BiosciencesFriendswood, TX, US · est. 2008

Castle Biosciences, Inc.: A U.S. biotech firm offering diagnostic and prognostic cancer testing solutions.

Public · $354.3M543

Epic SciencesSan Diego, CA, USCancer Diagnosticsest. 2008Epic SciencesSan Diego, CA, US · est. 2008

Epic Sciences: A medical diagnostics firm specializing in circulating tumor cell analysis.

Series G · $219.5M114

OncoTartisBuffalo, NY, USAnti-Cancer Drugsest. 2011

OncoTartisBuffalo, NY, US · est. 2011

OncoTartis, Inc.: A private biotech firm innovating targeted anti-cancer drugs for specific malignancies.

Series A · $6M8

Ascenta TherapeuticsMalvern, PA, USCancer Treatmentsest. 2003Ascenta TherapeuticsMalvern, PA, US · est. 2003

Ascenta Therapeutics: A clinical-stage biopharma company innovating new cancer treatments.

Public · $87.8M75

OnCusp TherapeuticsNew York City, NY, USCancer Treatmentsest. 2021OnCusp TherapeuticsNew York City, NY, US · est. 2021

OnCusp Therapeutics: Innovating oncology treatments for global cancer patients.

Series A · $125M14

NeurOpAtlanta, GA, USPharmaceuticalsest. 2002

NeurOpAtlanta, GA, US · est. 2002

Atlanta-based NeurOp Corp. develops disease-activated molecules for treating CNS diseases like Parkinson's and Alzheimer's.

Seed · $580k5

NeuroGenetic PharmaceuticalsDel Mar, CA, USDrugs, Pharmaceuticalsest. 2009NeuroGenetic PharmaceuticalsDel Mar, CA, US · est. 2009

US-based NeuroGenetic Pharmaceuticals pioneers in developing innovative drugs to prevent neurodegenerative diseases.

NeurolixisSan Diego, CA, USPharmaceuticalsest. 2011NeurolixisSan Diego, CA, US · est. 2011

San Diego-based Neurolixis, a biopharmaceutical firm innovating treatments for central nervous system diseases.

NeuroPro TherapeuticsYachats, OR, USPharmaceuticalsest. 2014

NeuroPro TherapeuticsYachats, OR, US · est. 2014

NeuroPro Therapeutics: Developing pharmaceutical solutions for epilepsy and neurological disorders.

Series A · $5.1M5

Neurana PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2013Neurana PharmaceuticalsSan Diego, CA, US · est. 2013

Neurana Pharmaceuticals: A US-based specialty pharma company innovating treatments for CNS diseases.

Series A · $60M5

NeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30